| Literature DB >> 25068720 |
Catherine E Oldenburg1, Amaya G Perez-Brumer2, Sari L Reisner1, Jason Mattie3, Till Bärnighausen4, Kenneth H Mayer5, Matthew J Mimiaga6.
Abstract
BACKGROUND: Men who engage in transactional sex, the exchange of sex for money, goods, or other items of value, are thought to be at increased risk of HIV, but there have been no systematic attempts to characterize HIV burden in this population. We undertook a systematic review and meta-analysis to quantify the burden in this population compared with that of men in the general population to better inform future HIV prevention efforts.Entities:
Mesh:
Year: 2014 PMID: 25068720 PMCID: PMC4113434 DOI: 10.1371/journal.pone.0103549
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow diagram of included studies.
Pooled HIV prevalence by HIV measurement and sample size.
| N (k) | Pooled HIV Prevalence (95% CI) | |
| Overall | 34,531 (88) | 11.9% (10.9 to 12.9%) |
| Biological assay | 32,007 (71) | 10.7% (9.7 to 11.8%) |
| Self-report, untested or unknown status excluded from calculation | 2,524 (17) | 20.6% (14.5 to 26.8%) |
| Self-report, untested or unknown status assumed to be negative | 3,109 (17) | 13.3% (9.6 to 17.0%) |
| Biological assay, ≥50 participants in study | 31,924 (66) | 10.5% (9.4 to 11.5%) |
N = number of subjects; k = number of studies; 95% CI = 95% Confidence Interval.
Pooled HIV prevalence among men who engage in transactional sex by region, country, and definition of transactional sex.
| Overall (95% CI) | Male sex workers | Exchanged sex in last 12 months | Ever exchanged sex |
| |||||
| N (k) | HIV Prevalence (95%CI) | N (k) | HIV Prevalence (95%CI) | N (k) | HIV Prevalence (95%CI) | N (k) | HIV Prevalence (95%CI) | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bangladesh | 985 (1) | 0.0% (0.0 to 0.0%) | 985 (1) | 0.0% (0.0 to 0.0%) | – | – | – | – | – |
| India | 2,211 (2) | 11.8% (6.0 to 17.6%) | 100 (2) | 24.0% (15.6 to 32.4%) | – | – | 2,211 (2) | 11.8% (6.0 to 17.6%) | – |
| Nepal | 218 (2) | 3.5% (1.0 to 5.9%) | 218 (2) | 3.5% (1.0 to 5.9%) | – | – | – | – | – |
| Pakistan | 11,039 (9) | 1.2% (0.6 to 1.7%) | 10,230 (8) | 1.0% (0.5 to 1.6%) | 809 (1) | 2.0% (1.0 to 2.9%) | – | – | – |
|
|
|
|
|
|
|
|
|
|
|
| Indonesia | 250 (1) | 3.6% (1.3 to 5.9%) | 250 (1) | 3.6% (1.3 to 5.9%) | – | – | – | – | |
| Laos | 119 (1) | 8.4% (3.4 to 13.4%) | – | – | 119 (1) | 8.4% (3.4 to 13.4%) | – | – | – |
| Thailand | 3,201 (7) | 17.5% (13.7 to 21.2%) | 2,211 (5) | 15.6% (11.6 to 19.6%) | 659 (1) | 17.5% (14.6 to 20.3%) | 484 (2) | 23.2% (13.9 to 32.5%) | – |
| Vietnam | 907 (3) | 6.8% (0.0 to 13.8%) | 831 (2) | 9.9% (2.8 to 17.0%) | – | – | 76 (1) | 0.0% (0.0 to 0.0%) | – |
|
|
|
|
|
|
|
|
|
|
|
| Argentina | 170 (2) | 11.2% (6.4 to 15.9%) | 114 (1) | 11.4% (5.6 to 17.2%) | – | – | 56 (1) | 10.7% (2.6 to 18.8%) | – |
| Ecuador | 76 (1) | 19.7% (10.8 to 28.7%) | – | – | – | – | 76 (1) | 19.7% (10.8 to 28.7%) | – |
| El Salvador | 156 (1) | 19.2% (13.0 to 25.4%) | – | – | – | – | 156 (1) | 19.2% (13.0 to 25.4%) | – |
| Mexico | 507 (2) | 17.2% (12.0 to 22.5%) | 507 (2) | 17.2% (12.0 to 22.5%) | – | – | – | – | |
| Peru | 478 (2) | 27.3% (20.2 to 34.4%) | 478 (2) | 27.3% (20.2 to 34.4%) | – | – | – | – | – |
| Uruguay | 317 (1) | 21.8% (17.2 to 26.3%) | 317 (1) | 21.8% (17.2 to 26.3%) | – | – | – | – | – |
|
|
|
|
|
|
|
|
|
|
|
| Cote d’Ivoire | 96 (1) | 50.0% (40.0 to 60.0%) | 96 (1) | 50.0% (40.0 to 60.0%) | – | – | – | – | – |
| Kenya | 1,290 (4) | 33.2% (21.0 to 45.3%) | 1,290 (4) | 33.2% (21.0 to 45.3%) | – | – | – | – | – |
| Senegal | 93 (1) | 26.9 (17.9 to 35.9%) | – | – | 93 (1) | 26.9 (17.9 to 35.9%) | – | – | – |
| Uganda | 129 (1) | 12.4% (6.7 to 18.1%) | – | – | – | – | 129 (1) | 12.4% (6.7 to 18.1%) | – |
|
|
|
|
|
|
|
|
|
|
|
| Belgium | 120 (1) | 10.8% (5.3 to 16.4%) | 120 (1) | 10.8% (5.3 to 16.4%) | – | – | – | – | – |
| Czech Republic | 230 (1) | 0.9% (0.0 to 2.1%) | – | – | – | – | 230 (1) | 0.9% (0.0 to 2.1%) | – |
| Israel | 53 (1) | 5.7% (0.0 to 11.9%) | 53 (1) | 5.7% (0.0 to 11.9%) | – | – | – | – | – |
| Netherlands | 99 (1) | 11.1% (4.9 to 17.3%) | 99 (1) | 11.1% (4.9 to 17.3%) | – | – | – | – | – |
| Russia | 50 (1) | 18.0% (7.4 to 28.6%) | 50 (1) | 18.0% (7.4 to 28.6%) | – | – | – | – | – |
| Spain | 666 (2) | 14.2% (9.6 to 18.8%) | 666 | 14.2% (9.6 to 18.8%) | – | – | – | – | – |
| United Kingdom | 636 (1) | 9.3% (7.0 to 11.5%) | – | – | 636 (1) | 9.3% (7.0 to 11.5%) | – | – | – |
|
|
|
| – | – |
|
|
|
|
|
| United States | 349 (2) | 19.3% (8.0 to 30.6%) | – | – | – | – | 349 (2) | 19.5% (13.7 to 25.3%) | – |
| Canada | 258 (2) | 14.1% (0.0 to 38.4%) | – | – | 108 (1) | 26.9% (18.5 to 35.2%) | 150 (1) | 2.0% (0 to 4.2%) | – |
|
|
|
|
|
|
|
|
|
|
|
Analyses restricted to individual studies reporting ≥50 participants and biological assay-confirmed HIV prevalence;
Type-3 P-value from random effects meta-regression adjusted for country-level HIV prevalence among males aged 15+ (presented for regions).
N = number of subjects; k = number of studies; 95% CI = 95% Confidence Interval.
Figure 2Pooled HIV prevalence by country among studies reporting biologically-confirmed HIV prevalence with a sample size of ≥50 (N = 66).
Prevalence ratios comparing pooled HIV prevalence among men who engage in transactional sex to general population men aged 15 and older.
| N (k) | HIV Prevalence | Country-Wide HIVPrevalence, Males 15+ | I | Prevalence Ratio | |
|
|
|
| 0.10% |
|
|
|
|
|
|
|
| |
| Bangladesh | 985 (1) | 0.0% (0.0 to 0.0%) | 0.0093% | 5.5 (0.3 to 87.3) | |
| India | 2,211 (3) | 11.8% (6.0 to 17.6%) | 0.34% | 34.4 (20.6 to 57.6) | |
| Nepal | 218 (2) | 3.5% (1.0 to 5.9%) | 0.46% | 8.2 (4.2 to 16.2) | |
| Pakistan | 11,039 (9) | 1.2% (0.6 to 1.7%) | 0.11% | 11.0 (6.1 to 19.8) | |
|
|
|
|
|
| |
| Indonesia | 250 (1) | 3.6% (1.3 to 5.9%) | 0.24% | 14.7 (7.7 to 27.9) | |
| Laos | 119 (1) | 8.4% (3.4 to 13.4%) | 0.25% | 33.5 (18.5 to 60.7) | |
| Thailand | 3,201 (7) | 17.5% (13.7 to 21.2%) | 1.21% | 14.4 (11.8 to 17.7) | |
| Vietnam | 907 (3) | 6.8% (0.0 to 13.8%) | 0.59% | 12.7 (5.3 to 30.5) | |
|
|
|
|
|
| |
| Argentina | 170 (2) | 11.2% (6.4 to 15.9%) | 0.53% | 21.2 (13.9 to 32.4) | |
| Ecuador | 76 (1) | 19.7% (10.8 to 28.7%) | 0.51% | 39.0 (24.8 to 61.4) | |
| El Salvador | 156 (1) | 19.2% (13.0 to 25.4%) | 1.10% | 17.5 (12.7 to 24.1) | |
| Mexico | 507 (2) | 17.2% (12.0 to 22.5%) | 0.42% | 41.0 (30.2 to 55.8) | |
| Peru | 478 (2) | 27.3% (20.2 to 34.4%) | 0.56% | 49.2 (37.9 to 63.9) | |
| Uruguay | 317 (1) | 21.8% (17.2 to 26.3%) | 0.55% | 39.7 (32.2 to 49.0) | |
|
|
|
|
|
| |
| Cote d’Ivoire | 96 (1) | 50.0% (40.0 to 60.0%) | 2.56% | 19.5 (16.0 to 23.8) | |
| Kenya | 1,290 (4) | 33.2% (21.0 to 45.3%) | 4.60% | 6.9 (4.7 to 10.0) | |
| Senegal | 93 (1) | 26.9 (17.9 to 35.9%) | 0.69% | 38.7 (27.7 to 54.1) | |
| Uganda | 129 (1) | 14.2% (7.7 to 20.6%) | 5.81% | 2.4 (1.5 to 3.8) | |
|
|
|
|
|
| |
| Belgium | 120 (1) | 10.8% (5.3 to 16.4%) | 0.23% | 46.4 (27.8 to 77.6) | |
| Czech Republic | 230 (1) | 0.9% (0.0 to 2.1%) | 0.033% | 26.5 (6.7 to 105.4) | |
| Israel | 53 (1) | 5.7% (0.0 to 11.9%) | 0.20% | 27.7 (9.2 to 83.2) | |
| Netherlands | 99 (1) | 11.1% (4.9 to 17.3%) | 0.24% | 46.3 (26.5 to 80.8) | |
| Russia | 50 (1) | 18.0% (7.4 to 28.6%) | 0.89% | 20.3 (11.2 to 36.6) | |
| Spain | 666 (2) | 14.2% (9.6 to 18.8%) | 0.52% | 27.6 (20.0 to 38.2) | |
| United Kingdom | 636 (1) | 9.3% (7.0 to 11.5%) | 0.23% | 39.6 (31.1 to 50.5) | |
|
|
|
|
|
| |
| United States | 349 (2) | 19.3% (8.0 to 30.6%) | 0.77% | 24.6 (13.3 to 45.3) | |
| Canada | 258 (2) | 14.1% (0.0 to 38.4%) | 0.38% | 19.8 (0.67 to 581.5) | |
|
|
|
|
|
|
Among studies confirming HIV infection with a biological assay and among studies reporting ≥50 participants;
All prevalence ratios significant (P<0.05) except for Bangladesh and Canada.
N = number of subjects; k = number of studies; I2 = variation in pooled prevalence ratio due to heterogeneity; 95% CI = 95% Confidence Interval.
Proportion of studies reporting individual factors that affect vulnerability to HIV by region, overall and specifically among men who engage in transactional sex.
| Total Number of Studies | Any Drug Use | Injection Drug Use | Depression | Childhood Sexual Abuse | Unprotected Anal Sex | STI | |
|
| 14 | ||||||
| Overall | 8 (57.1%) | 4 (28.6%) | 2 (14.3%) | 2 (14.3%) | 14 (100%) | 12 (85.7%) | |
| Transactional Sex | 4 (28.6%) | 1 (7.1%) | 2 (14.3%) | 2 (14.3%) | 12 (85.7%) | 7 (50.0%) | |
|
| 16 | ||||||
| Overall | 6 (37.5%) | 11 (68.8%) | 0 (0%) | 1 (6.3%) | 16 (100%) | 12 (75.0%) | |
| Transactional Sex | 6 (37.5%) | 10 (62.5%) | 0 (0%) | 1 (6.3%) | 15 (93.8%) | 10 (62.5%) | |
|
| 15 | ||||||
| Overall | 10 (66.7%) | 6 (40.0%) | 1 (6.7%) | 0 (0%) | 14 (93.3%) | 10 (66.7%) | |
| Transactional Sex | 8 (53.3%) | 6 (40.0%) | 1 (6.7%) | 0 (0%) | 13 (86.7%) | 7 (46.7%) | |
|
| 11 | ||||||
| Overall | 7 (63.6%) | 2 (18.2%) | 1 (9.1%) | 1 (9.1%) | 9 (81.8%) | 8 (72.7%) | |
| Transactional Sex | 2 (18.2%) | 1 (9.1%) | 1 (9.1%) | 1 (9.1%) | 7 (63.6%) | 4 (36.4%) | |
|
| 9 | ||||||
| Overall | 6 (66.7%) | 5 (55.6%) | 1 (11.1%) | 1 (11.1%) | 9 (100%) | 6 (66.7%) | |
| Transactional Sex | 4 (44.4%) | 3 (33.3%) | 0 (0%) | 1 (11.1%) | 7 (77.8%) | 4 (44.4%) | |
|
| 9 | ||||||
| Overall | 5 (55.6%) | 6 (66.7%) | 0 (0%) | 2 (22.2%) | 5 (55.6%) | 6 (66.7%) | |
| Transactional Sex | 5 (55.6%) | 6 (66.7%) | 0 (0%) | 2 (22.2%) | 5 (55.6%) | 6 (66.7%) | |
|
| 14 | ||||||
| Overall | 10 (71.4%) | 12 (85.7%) | 3 (21.4%) | 4 (28.6%) | 10 (71.4%) | 6 (42.9%) | |
| Transactional Sex | 9 (64.3%) | 11 (78.6%) | 3 (21.4%) | 4 (28.6%) | 9 (64.3%) | 5 (35.7%) | |
|
| 88 | ||||||
| Overall | 52 (59.1%) | 46 (52.3%) | 8 (9.1%) | 11 (12.5%) | 77 (87.5%) | 60 (68.2%) | |
| Transactional Sex | 38 (43.2%) | 38 (43.2%) | 7 (8.0%) | 11 (12.5%) | 68 (77.3%) | 43 (48.9%) | |
|
| – | ||||||
| Overall | 0.61 | 0.005 | 0.45 | 0.29 | 0.003 | 0.39 | |
| Transactional Sex | 0.25 | <0.001 | 0.33 | 0.29 | 0.18 | 0.69 |
Including syphilis, gonorrhea, chlamydia, human papilloma virus (HPV), and/or herpes simplex virus (HSV);
Risk factor reported among any population in the study (i.e., men who have sex with men);
Risk factor reported specifically among men who engage in transactional sex;
Fisher’s exact test comparing frequency of reporting factors by geographic region of study, overall and among men who report transactional sex.